A farnesyltransferase inhibitor with antitumor activity
Related Products
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Tipifarnib

Item No. 11747

Technical Information
Formal Name
6-[(R)-amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone
CAS Number
192185-72-1
Synonyms
  • R 115777
Molecular Formula
C27H22Cl2N4O
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMSO: 10 mg/mlEthanol: 5 mg/ml
λmax
237, 285, 340 nm
SMILES
ClC1=CC=CC(C(C2=C3C=CC([C@@](C4=CC=C(Cl)C=C4)(N)C5=CN=CN5C)=C2)=CC(N3C)=O)=C1
InChi Code
InChI=1S/C27H22Cl2N4O/c1-32-16-31-15-25(32)27(30,18-6-9-20(28)10-7-18)19-8-11-24-23(13-19)22(14-26(34)33(24)2)17-4-3-5-21(29)12-17/h3-16H,30H2,1-2H3/t27-/m1/s1
InChi Key
PLHJCIYEEKOWNM-HHHXNRCGSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    Tipifarnib is a nonpeptidomimetic, CAAX-competitive inhibitor of farnesyltransferase (IC50 = 0.86 nM).1 It prevents farnesylation of Ras GTPases and has shown potent efficacy in various in vitro and in vivo tumor models.2,3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Bell, I.M. Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy? J. Med. Chem. 47(8), 1869-1878 (2004).

    2. Vigil, D., Cherfils, J., Rossman, K.L., et alRas superfamily GEFs and GAPs: Validated and tractable targets for cancer therapy? Nat. Rev. Cancer 10(12), 842-857 (2010).

    3. Appels, N.M.G.M., Beijnen, J.H., and Schellens, J.H.M. Development of farnesyl transferase inhibitors: A review. Oncologist 10(8), 565-578 (2005).